prednisone has been researched along with Polyradiculoneuropathy, Chronic Inflammatory Demyelinating in 39 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating: A slowly progressive autoimmune demyelinating disease of peripheral nerves and nerve roots. Clinical manifestations include weakness and sensory loss in the extremities and enlargement of peripheral nerves. The course may be relapsing-remitting or demonstrate a step-wise progression. Protein is usually elevated in the spinal fluid and cranial nerves are typically spared. GUILLAIN-BARRE SYNDROME features a relatively rapid progression of disease which distinguishes it from this condition. (Adams et al., Principles of Neurology, 6th ed, p1337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe two cases of CIDP secondary to treatment with combined ipilimumab and nivolumab in patients with metastatic melanoma that were successfully treated with prednisone and IVIG." | 3.91 | Chronic inflammatory demyelinating polyradiculoneuropathy secondary to immune checkpoint inhibitors in melanoma patients. ( Patel, AS; Sehdev, A; Snook, RJ, 2019) |
| " The treated group was administered with GTC and prednisone, while the control group with prednisone alone." | 2.74 | [Clinical observation on treatment of 10 patients with chronic inflammatory demyelinating polyneuropathy by gullong tongluo capsule combined with prednisone]. ( Chen, JL; Hu, JY; Zhang, ZH, 2009) |
| "Inflammatory peripheral neuropathies can be disabling for any patient." | 2.72 | Immunotherapy for Peripheral Nerve Disorders. ( Granger, A; Zakin, E, 2021) |
| "Eighteen of them also had monoclonal gammopathy of undetermined significance (MGUS)." | 2.69 | Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. ( Ciano, C; Fallica, E; Mariotti, C; Pareyson, D; Sghirlanzoni, A; Solari, A, 2000) |
| "Chronic inflammatory demyelinating polyradiculoneuropathy is an inflammatory disorder of nerve that usually presents with slowly progressive weakness and sensory loss and areflexia." | 2.42 | The treatment of chronic inflammatory demyelinating polyradiculoneuropathy. ( Kissel, JT, 2003) |
| "Chronic inflammatory demyelinating polyradiculoneuropathy is an autoimmune peripheral neuropathy and would be expected to benefit from corticosteroids." | 2.41 | Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. ( Hughes, RA; Mehndiratta, MM, 2001) |
| "Chronic inflammatory demyelinating polyradiculoneuropathy is a peripheral neuropathy caused by peripheral nerve inflammation probably due to autoimmunity and would be expected to benefit from corticosteroids." | 2.41 | Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. ( Hughes, RA; Mehndiratta, MM, 2002) |
| "Patients with CIDP respond adequately to steroid therapy and intravenous immunoglobulin (IVIG)." | 1.62 | Efficacy of long-term prednisone therapy in patients with chronic inflammatory demyelinating polyneuropathy (CIDP): a retrospective cohort study. ( Galnares-Olalde, JA; López-Hernández, JC; Mercado-Pompa, A; Pérez-Torres, T; Vargas-Cañas, ES, 2021) |
| "Seven clinically suspected CIDP patients who did not fulfill EFNS/PNS electrodiagnostic criteria for demyelinating neuropathy were enrolled in our study." | 1.48 | Diagnosing chronic inflammatory demyelinating polyradiculoneuropathy with triple stimulation technique. ( Cao, D; Guo, X; Hao, J; Yuan, T, 2018) |
| " Outcomes were number of responders to treatment, remission rate of treatment responders, overall probability of 5-year remission, and the occurrence of adverse events." | 1.48 | Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone. ( Basta, I; Doneddu, PE; Eftimov, F; Gallia, F; Nikolic, A; Nobile-Orazio, E; Peric, S; van Lieverloo, GGA; van Schaik, IN; Verhamme, C; Wieske, L, 2018) |
| "The patient had initially a sensory CIDP wich respond to prednisone." | 1.34 | [Chronic inflammatory demyelinating polyneuropathy (CIDP) revealing an associated disease diagnostic and therapeutic pitfalls]. ( Jaccard, A; Maisonobe, T, 2007) |
| "We present 4 patients with CIDP who required respiratory assistance and mechanical ventilation." | 1.33 | Chronic inflammatory demyelinating polyneuropathy and respiratory failure. ( Henderson, RD; Sandroni, P; Wijdicks, EF, 2005) |
| "The ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy (ataxic-CIDP) has been recently described as a subtype of chronic ataxic neuropathy, distinguished by steroid responsiveness and relative preservation of myelinated fibres at sural nerve biopsy." | 1.33 | Hyperpyrexia-triggered relapses in an unusual case of ataxic chronic inflammatory demyelinating polyradiculoneuropathy. ( Bertolasi, L; Ferrari, S; Mazzucco, S; Mezzina, C; Rizzuto, N; Tomelleri, G, 2006) |
| "Current electrodiagnostic criteria for CIDP are insensitive and may fail to diagnose the condition in a substantial number of patients." | 1.32 | Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. ( Brannagan, TH; Chin, RL; Latov, N; Magda, P; Sander, HW; Weimer, LH, 2003) |
| "The oedema was not explained by immobility, hypoproteinaemia or local factors." | 1.31 | Chronic inflammatory demyelinating polyradiculoneuropathy and severe peripheral oedema: a renal explanation. ( Healy, HG; Henderson, RD; Lander, CM; McCombe, PA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 22 (56.41) | 29.6817 |
| 2010's | 12 (30.77) | 24.3611 |
| 2020's | 5 (12.82) | 2.80 |
| Authors | Studies |
|---|---|
| López-Hernández, JC | 1 |
| Mercado-Pompa, A | 1 |
| Pérez-Torres, T | 1 |
| Galnares-Olalde, JA | 1 |
| Vargas-Cañas, ES | 1 |
| Patel, AS | 1 |
| Snook, RJ | 1 |
| Sehdev, A | 1 |
| George, IC | 1 |
| Kvalsund, M | 1 |
| Saylor, D | 1 |
| Rogers, AB | 1 |
| Zaidman, CM | 1 |
| Connolly, AM | 2 |
| Granger, A | 1 |
| Zakin, E | 1 |
| Hughes, RA | 6 |
| Mehndiratta, MM | 5 |
| Rajabally, YA | 1 |
| Shigemoto, R | 1 |
| Anno, T | 1 |
| Ohnuki, E | 1 |
| Kosaka, S | 1 |
| Okimoto, N | 1 |
| Kaku, K | 1 |
| Kaneto, H | 1 |
| Cao, D | 1 |
| Guo, X | 1 |
| Yuan, T | 1 |
| Hao, J | 1 |
| van Lieverloo, GGA | 1 |
| Peric, S | 1 |
| Doneddu, PE | 1 |
| Gallia, F | 1 |
| Nikolic, A | 1 |
| Wieske, L | 1 |
| Verhamme, C | 1 |
| van Schaik, IN | 2 |
| Nobile-Orazio, E | 1 |
| Basta, I | 1 |
| Eftimov, F | 1 |
| Russo, F | 1 |
| Vispi, M | 1 |
| Bocci, S | 1 |
| Mancini, V | 1 |
| Sirna, R | 1 |
| Giannini, F | 1 |
| Pellegrino, M | 1 |
| Herrera, I | 1 |
| Kam, Y | 1 |
| Whittaker, TJ | 1 |
| Champion, M | 1 |
| Ajlan, RS | 1 |
| Taylor, T | 1 |
| Netherton, SJ | 1 |
| Owen, CJ | 1 |
| Zochodne, DW | 1 |
| Kararizou, E | 1 |
| Anagnostou, E | 1 |
| Kapaki, E | 1 |
| Davaki, P | 1 |
| Oaklander, AL | 1 |
| Lunn, MP | 1 |
| Frost, C | 1 |
| Chalk, CH | 1 |
| Teasley, JE | 1 |
| Rigamonti, A | 1 |
| Lauria, G | 1 |
| Balgera, R | 1 |
| Agostoni, E | 1 |
| Hu, JY | 1 |
| Chen, JL | 1 |
| Zhang, ZH | 1 |
| Pavesi, G | 1 |
| Cattaneo, L | 1 |
| Marbini, A | 1 |
| Gemignani, F | 1 |
| Mancia, D | 1 |
| Haq, RU | 1 |
| Pendlebury, WW | 1 |
| Fries, TJ | 1 |
| Tandan, R | 1 |
| Kissel, JT | 1 |
| Magda, P | 1 |
| Latov, N | 1 |
| Brannagan, TH | 1 |
| Weimer, LH | 1 |
| Chin, RL | 1 |
| Sander, HW | 1 |
| Hengstman, GJ | 1 |
| Schelhaas, HJ | 1 |
| Zwarts, MJ | 1 |
| Henderson, RD | 2 |
| Sandroni, P | 1 |
| Wijdicks, EF | 1 |
| Sivakumar, K | 1 |
| Fife, TD | 1 |
| Siman-Tov, T | 1 |
| Meiner, V | 1 |
| Gadoth, N | 1 |
| Celik, Y | 1 |
| Turgut, N | 1 |
| Turgut, B | 1 |
| Pamuk, GE | 1 |
| Demir, M | 1 |
| Mazzucco, S | 1 |
| Ferrari, S | 1 |
| Mezzina, C | 1 |
| Tomelleri, G | 1 |
| Bertolasi, L | 1 |
| Rizzuto, N | 1 |
| Rossignol, E | 1 |
| D'Anjou, G | 1 |
| Lapointe, N | 1 |
| Haddad, E | 1 |
| Vanasse, M | 1 |
| Maisonobe, T | 1 |
| Jaccard, A | 1 |
| Valenzise, M | 1 |
| Meloni, A | 1 |
| Betterle, C | 1 |
| Giometto, B | 1 |
| Autunno, M | 1 |
| Mazzeo, A | 1 |
| Cao, A | 1 |
| De Luca, F | 1 |
| Healy, HG | 1 |
| McCombe, PA | 1 |
| Lander, CM | 1 |
| Sghirlanzoni, A | 1 |
| Solari, A | 1 |
| Ciano, C | 1 |
| Mariotti, C | 1 |
| Fallica, E | 1 |
| Pareyson, D | 1 |
| Miyamoto, K | 1 |
| Oka, N | 1 |
| Kawasaki, T | 1 |
| Akiguchi, I | 1 |
10 reviews available for prednisone and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
| Article | Year |
|---|---|
Immunotherapy for Peripheral Nerve Disorders.
Topics: Adrenal Cortex Hormones; Aged; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunother | 2021 |
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Dexamethasone; Glucocorticoids; Humans; Polyradiculoneuropathy, Chronic In | 2017 |
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Dexamethasone; Glucocorticoids; Humans; Polyradiculoneuropathy, Chronic In | 2015 |
Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Topics: Adrenal Cortex Hormones; Azathioprine; Dexamethasone; Humans; Immunoglobulins, Intravenous; Immunosu | 2017 |
Initial treatment of childhood chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Adrenal Cortex Hormones; Adult; Child; Cyclophosphamide; Humans; Immunoglobulins, Intravenous; Immun | 2008 |
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Dexamethasone; Glucocorticoids; Humans; Polyradiculoneuropathy, Chronic In | 2012 |
The treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Polyradicu | 2003 |
Chronic inflammatory demyelinating polyneuropathy in childhood.
Topics: Anti-Inflammatory Agents; Child, Preschool; Diagnosis, Differential; Female; Humans; Immunoglobulins | 2001 |
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Humans; Polyradiculoneuropathy, Chronic Inflammat | 2001 |
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Humans; Polyradiculoneuropathy, Chronic Inflammat | 2002 |
2 trials available for prednisone and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
| Article | Year |
|---|---|
[Clinical observation on treatment of 10 patients with chronic inflammatory demyelinating polyneuropathy by gullong tongluo capsule combined with prednisone].
Topics: Adolescent; Adult; Drugs, Chinese Herbal; Female; Humans; Male; Medicine, Chinese Traditional; Middl | 2009 |
Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Child; Cyclophosphamide; Electrophy | 2000 |
27 other studies available for prednisone and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
| Article | Year |
|---|---|
Efficacy of long-term prednisone therapy in patients with chronic inflammatory demyelinating polyneuropathy (CIDP): a retrospective cohort study.
Topics: Adult; Cohort Studies; Female; Glucocorticoids; Humans; Male; Middle Aged; Polyradiculoneuropathy, C | 2021 |
Chronic inflammatory demyelinating polyradiculoneuropathy secondary to immune checkpoint inhibitors in melanoma patients.
Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Female; | 2019 |
A case of combined central and peripheral demyelination in Zambia.
Topics: Adult; Azathioprine; Comorbidity; Demyelinating Diseases; Developing Countries; Glucocorticoids; Hum | 2020 |
Pulse oral corticosteroids in pediatric chronic inflammatory demyelinating polyneuropathy.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Child; Child, Preschool; Duration of Ther | 2020 |
Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long-term therapy for chronic inflammatory demyelinating polyneuropathy.
Topics: Diabetes Mellitus, Type 1; Glucocorticoids; Humans; Immunization, Passive; Male; Methylprednisolone; | 2018 |
Diagnosing chronic inflammatory demyelinating polyradiculoneuropathy with triple stimulation technique.
Topics: Administration, Oral; Adult; Aged; Disability Evaluation; Electrodiagnosis; Female; Glucocorticoids; | 2018 |
Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone.
Topics: Adrenal Cortex Hormones; Bendamustine Hydrochloride; Dexamethasone; Female; Follow-Up Studies; Human | 2018 |
New onset psoriasis in a patient with chronic inflammatory demyelinating polyneuropathy treated with Rituximab.
Topics: Adult; Combined Modality Therapy; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immu | 2020 |
Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy.
Topics: Administration, Oral; Bone Density Conservation Agents; Cyclosporine; Female; Glucocorticoids; Human | 2019 |
Chronic inflammatory demyelinating polyradiculoneuropathy: in a remote northern Ontario hospital.
Topics: Aged; Electromyography; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; | 2013 |
Monophasic CIDP Associated with Autoimmune Hemolytic Anemia.
Topics: Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Glucocorticoids; Humans; Male; Polyradiculoneuropa | 2014 |
Chronic inflammatory demyelinating polyneuropathy associated with neurosyphilis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Biopsy; Cognitive Dysfunction; Electromyography; Ex | 2015 |
Subacute inflammatory polyradiculopathy associated with Sjögren's syndrome.
Topics: Aged; Disease Progression; Electrodiagnosis; Female; Humans; Immunosuppressive Agents; Magnetic Reso | 2009 |
Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy.
Topics: Axons; Azathioprine; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Female; Hu | 2002 |
Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Topics: Adjuvants, Immunologic; Adult; Azathioprine; Diabetic Neuropathies; Female; Humans; Immunoglobulins, | 2003 |
Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
Topics: Action Potentials; Adult; Aged; Cohort Studies; Disability Evaluation; Electrodiagnosis; Female; Glu | 2003 |
Auditory dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Evoked Potentials, Auditory, Brain Stem; Functional L | 2004 |
Chronic inflammatory demyelinating polyneuropathy and respiratory failure.
Topics: Aged; Azathioprine; Biopsy; Coma; Cyclophosphamide; Electromyography; Female; Follow-Up Studies; Hum | 2005 |
Autoimmune hearing loss in chronic inflammatory demyelinating polyneuropathy.
Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Cochlea; Female; Hair Cells, Auditory; Hearing Loss | 2005 |
Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
Topics: Achilles Tendon; Adult; Brain; Chenodeoxycholic Acid; Cholestanetriol 26-Monooxygenase; Cholestanol; | 2006 |
Chronic idiopathic demyelinating polyneuropathy (CIDP) associated with Kaposi's sarcoma.
Topics: Aged; Anti-Inflammatory Agents; Electromyography; Female; Humans; Polyradiculoneuropathy, Chronic In | 2006 |
Hyperpyrexia-triggered relapses in an unusual case of ataxic chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Ataxia; Electromyography; Fever; Humans; Immunoglobulins, Intravenous; Imm | 2006 |
Evolution and treatment of childhood chronic inflammatory polyneuropathy.
Topics: Acute Disease; Adolescent; Azathioprine; Child; Child, Preschool; Disease Progression; Female; Gluco | 2007 |
[Chronic inflammatory demyelinating polyneuropathy (CIDP) revealing an associated disease diagnostic and therapeutic pitfalls].
Topics: Anti-Infective Agents; Electrodiagnosis; Humans; Hypertrichosis; Male; Median Nerve; Middle Aged; Mo | 2007 |
Chronic inflammatory demyelinating polyneuropathy as a possible novel component of autoimmune poly-endocrine-candidiasis-ectodermal dystrophy.
Topics: Administration, Oral; Adolescent; AIRE Protein; Alleles; Biopsy; DNA Mutational Analysis; Electromyo | 2009 |
Chronic inflammatory demyelinating polyradiculoneuropathy and severe peripheral oedema: a renal explanation.
Topics: Anti-Inflammatory Agents; Edema; Glomerulosclerosis, Focal Segmental; Humans; Kidney Glomerulus; Mal | 2000 |
A case of chronic inflammatory demyelinating polyneuropathy with antigalactocerebroside antibody.
Topics: Activities of Daily Living; Adult; Autoantibodies; Cerebrospinal Fluid Proteins; Electrophysiology; | 2000 |